MXPA05006804A - Identificacion, monitoreo y tratamiento de enfermedad infecciosa y caracterizacion de condiciones inflamatorias relacionadas con enfermedad infecciosa usando perfiles de expresion genica. - Google Patents

Identificacion, monitoreo y tratamiento de enfermedad infecciosa y caracterizacion de condiciones inflamatorias relacionadas con enfermedad infecciosa usando perfiles de expresion genica.

Info

Publication number
MXPA05006804A
MXPA05006804A MXPA05006804A MXPA05006804A MXPA05006804A MX PA05006804 A MXPA05006804 A MX PA05006804A MX PA05006804 A MXPA05006804 A MX PA05006804A MX PA05006804 A MXPA05006804 A MX PA05006804A MX PA05006804 A MXPA05006804 A MX PA05006804A
Authority
MX
Mexico
Prior art keywords
infectious disease
inflammatory conditions
conditions related
characterization
identification
Prior art date
Application number
MXPA05006804A
Other languages
English (en)
Spanish (es)
Inventor
John C Cheronis
Original Assignee
Source Precision Medicine Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Source Precision Medicine Inc filed Critical Source Precision Medicine Inc
Publication of MXPA05006804A publication Critical patent/MXPA05006804A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/136Screening for pharmacological compounds
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
MXPA05006804A 2002-12-19 2003-12-19 Identificacion, monitoreo y tratamiento de enfermedad infecciosa y caracterizacion de condiciones inflamatorias relacionadas con enfermedad infecciosa usando perfiles de expresion genica. MXPA05006804A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43525702P 2002-12-19 2002-12-19
PCT/US2003/040551 WO2004057034A1 (en) 2002-12-19 2003-12-19 Identification, monitoring and treatment of infectious disease and characterization of inflammatory conditions related to infectious disease using gene expression profiles

Publications (1)

Publication Number Publication Date
MXPA05006804A true MXPA05006804A (es) 2006-03-30

Family

ID=32682206

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05006804A MXPA05006804A (es) 2002-12-19 2003-12-19 Identificacion, monitoreo y tratamiento de enfermedad infecciosa y caracterizacion de condiciones inflamatorias relacionadas con enfermedad infecciosa usando perfiles de expresion genica.

Country Status (8)

Country Link
EP (1) EP1579008A1 (https=)
JP (2) JP2006510382A (https=)
CN (1) CN1751129B (https=)
AU (1) AU2003303238B2 (https=)
BR (1) BR0317612A (https=)
CA (1) CA2511237A1 (https=)
MX (1) MXPA05006804A (https=)
WO (1) WO2004057034A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0316232A (pt) 2002-11-12 2005-10-04 Becton Dickinson Co Métodos para determinar o estado de sepsia, para prognosticar o começo de sepsia e para diagnosticar a sìndrome de resposta inflamatória sistêmica em um indivìduo
EP2128270B1 (en) 2003-08-08 2012-10-03 Genenews Inc. Osteoarthritis biomarkers and uses thereof
JP2008538007A (ja) 2005-04-15 2008-10-02 ベクトン,ディッキンソン アンド カンパニー 敗血症の診断
EP1945814A2 (en) * 2005-09-27 2008-07-23 Source MDX Gene expression profiling for identification monitoring and treatment of rheumatoid arthritis
CA2652239A1 (en) * 2006-05-16 2007-11-29 Source Mdx Assessment of effect of an agent on a human biological condition using rodent gene expression panels
US20100267575A1 (en) * 2006-10-17 2010-10-21 Childrens Hospital Medical Center Gene array technique for predicting response in inflammatory bowel diseases
DE102007036678B4 (de) * 2007-08-03 2015-05-21 Sirs-Lab Gmbh Verwendung von Polynukleotiden zur Erfassung von Genaktivitäten für die Unterscheidung zwischen lokaler und systemischer Infektion
RU2612884C2 (ru) * 2010-04-02 2017-03-13 Курна, Инк. Лечение заболеваний, связанных с колониестимулирующим фактором 3 (csf3), путем ингибирования природного антисмыслового транскрипта k csf3
GB201304626D0 (en) * 2013-03-14 2013-05-01 Univ Cardiff Method of identifying a bacterial infection
CN107710207B (zh) * 2015-03-12 2022-03-08 皇家飞利浦有限公司 感染管理和控制
US11031119B2 (en) * 2019-11-13 2021-06-08 Cube Click, Inc. Dental images processed with deep learning for national security
CN118824376B (zh) * 2024-09-18 2025-01-21 江苏省疾病预防控制中心(江苏省预防医学科学院) 基于元学习技术的呼吸系统传染病人工智能辅助筛查系统

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998024935A1 (en) * 1996-12-06 1998-06-11 Urocor, Inc. Diagnosis of disease state using mrna profiles
CA2378008A1 (en) * 1999-06-28 2001-04-12 Source Precision Medicine, Inc. Systems and methods for characterizing a biological condition or agent using calibrated gene expression profiles
US6964850B2 (en) * 2001-11-09 2005-11-15 Source Precision Medicine, Inc. Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles

Also Published As

Publication number Publication date
CA2511237A1 (en) 2004-07-08
AU2003303238B2 (en) 2010-07-22
BR0317612A (pt) 2005-12-06
AU2003303238A1 (en) 2004-07-14
JP2010227111A (ja) 2010-10-14
CN1751129B (zh) 2014-07-23
WO2004057034A1 (en) 2004-07-08
CN1751129A (zh) 2006-03-22
EP1579008A1 (en) 2005-09-28
JP2006510382A (ja) 2006-03-30

Similar Documents

Publication Publication Date Title
WO2007038754A3 (en) Gene expression profiling for identification monitoring and treatment of rheumatoid arthritis
WO2008069881A3 (en) Gene expression profiling for identification, monitoring and treatment of melanoma
WO2008063414A3 (en) Gene expression profiling for identification, monitoring, and treatment of colorectal cancer
WO2008063413A3 (en) Gene expression profiling for identification, monitoring, and treatment of lung cancer
WO2008143639A3 (en) Gene expression profiling for identification, monitoring, and treatment of cervical cancer
WO2008123866A3 (en) Gene expression profiling for identification, monitoring and treatment of ovarian cancer
WO2008121132A3 (en) Gene expression profiling for identification, monitoring, and treatment of prostate cancer
WO2010006048A3 (en) Gene expression profiling for predicting the survivability of prostate cancer subjects
WO2008082529A3 (en) Gene expression profiling for identification, monitoring, and treatment of ocular disease
MXPA05006804A (es) Identificacion, monitoreo y tratamiento de enfermedad infecciosa y caracterizacion de condiciones inflamatorias relacionadas con enfermedad infecciosa usando perfiles de expresion genica.
ATE497361T1 (de) Verfahren zum nachweis von mehreren analyten
DE60035196D1 (de) Verfahren zum Charakterisieren von biologischen Bedingungen, die kalibrierte Genexpressionsprofile verwenden
EP1711802A4 (en) SYSTEMS AND METHOD FOR IMPROVING ELECTROCHEMICAL ANALYTIC SENSORS
ATE363228T1 (de) Kalibrierverfahren für glukoseüberwachungsvorrichtungen
ATE414166T1 (de) Glukosebiosensor und verfahren
DE60020119D1 (de) Verfahren und Vorrichtung zur Untersuchung von Wirksstoffskandidaten und zur Bestimmung ihrer pharmakokinetischen Parametern
EP2343117A3 (en) Method and apparatus for monitoring polyolefin production
ATE462350T1 (de) Verfahren und gerät zur laufenden überwachung der konzentration eines analyten
WO2004099432A3 (en) Identification of biomarkers for detecting pancreatic cancer
WO2003066876A3 (en) An apparatus and methods for using biological material to discriminate an agent
EP2494922A3 (en) Processing analyte sensor data
WO2003040728A3 (en) Method and apparatus for the determination of glucose
WO2003069377A3 (en) Method and apparatus for characterization of devices and circuits
ATE343125T1 (de) Verfahren zum kalibrieren einer spektroskopievorrichtung
EP1260178A3 (en) Technique for diagnosing attention deficit hyperactivity disorder